Page last updated: 2024-08-24

imirestat and Diabetes Mellitus, Type 1

imirestat has been researched along with Diabetes Mellitus, Type 1 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blessing, K; Kador, PF; Makita, J; Randazzo, J; Zhang, P1
Averbuch, M; Brazzell, RK; Dobbs, RE; Liao, JC; Weintraub, M1

Trials

1 trial(s) available for imirestat and Diabetes Mellitus, Type 1

ArticleYear
Red blood cell sorbitol lowering effects and tolerance of single doses of AL 1576 (HOE 843) in diabetic patients.
    Journal of clinical pharmacology, 1988, Volume: 28, Issue:8

    Topics: Adolescent; Adult; Aldehyde Reductase; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Double-Blind Method; Erythrocytes; Female; Fluorenes; Humans; Hydantoins; Hypoglycemic Agents; Male; Middle Aged; Random Allocation; Sorbitol; Sugar Alcohol Dehydrogenases

1988

Other Studies

1 other study(ies) available for imirestat and Diabetes Mellitus, Type 1

ArticleYear
Orally active multi-functional antioxidants delay cataract formation in streptozotocin (type 1) diabetic and gamma-irradiated rats.
    PloS one, 2011, Apr-26, Volume: 6, Issue:4

    Topics: Administration, Oral; Animals; Antioxidants; Body Weight; Cataract; Diabetes Mellitus, Type 1; Disease Progression; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Fluorenes; Gamma Rays; Heat-Shock Proteins; Humans; Hydantoins; Hyperglycemia; Lens Capsule, Crystalline; Pigmentation; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Streptozocin; Stress, Physiological

2011